Report error Found 349 Enz. Inhib. hit(s) with Target = 'Microtubule-associated proteins 1A/1B light chain 3B'
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 3nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 7.60nMAssay Description:Inhibition of GST-tagged LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate add...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 17nMAssay Description:Inhibition of GST-tagged wild type LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by sub...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 17nMAssay Description:Inhibition of LC3B (unknown origin) by Alphascreen assayMore data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 34nMAssay Description:Inhibition of GST-tagged LC3B (unknown origin) using biotin-labeled LBP2 as substrate preincubated with compound for 12 hrs followed by substrate add...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair
TargetMicrotubule-associated proteins 1A/1B light chain 3B(Human)
Wigen Biomedicine Technology (Shanghai)
US Patent
Wigen Biomedicine Technology (Shanghai)
US Patent
Affinity DataIC50: 50nMAssay Description:By constructing a prokaryotic expression system, the LC3B protein was successfully expressed and purified, and a preliminary screening and verificati...More data for this Ligand-Target Pair















































